-

Judy Ringholz Joins Conflixis as Senior Managing Director

DALLAS--(BUSINESS WIRE)--Conflixis, a leading provider of conflict of interest disclosure and risk assessment solutions for the healthcare industry, is pleased to announce that Judy Ringholz has joined the company as Senior Managing Director. In this role, Judy will assist with thought leadership, product innovation, and business development, bringing her deep expertise in healthcare compliance to support Conflixis’s mission of helping healthcare organizations manage risk effectively.

Judy is a widely recognized leader in healthcare compliance. She has held compliance leadership roles at the corporate level within five major healthcare systems and previously served as a compliance enforcement attorney for the U.S. Department of Health and Human Services Office of Inspector General (OIG). Her extensive experience in regulatory compliance, enforcement, and risk mitigation makes her a valuable addition to the Conflixis team.

Judy is a sought-after speaker on healthcare compliance topics at local, regional, and national conferences and has been published in *Legal Nurse Consulting: Principles and Practice*, the *Journal of Health Care Compliance*, and *Compliance Today*. She also serves on the editorial committee for the *Complete Healthcare Compliance Manual*. In addition, Judy served on the Board of Directors for the Health Care Compliance Association (HCCA) and the Society of Corporate Compliance and Ethics (SCCE) for the past six years.

“We are thrilled to welcome Judy to Conflixis,” said Aaron Narva, CEO. “Her expertise in compliance and risk management, combined with her leadership in the field, will be instrumental in enhancing our solutions and expanding our impact. Judy’s insights will help us continue to drive innovation and support healthcare organizations in navigating the complexities of compliance and conflict of interest management.”

Judy’s appointment reinforces Conflixis’s commitment to delivering best-in-class solutions for healthcare compliance and risk assessment. Her leadership will help shape the company’s growth and ensure that healthcare organizations have the tools they need to maintain integrity and transparency. Judy can be reached at judy@conflixis.com, or for more information about Conflixis and its solutions, go to www.conflixis.com.

Conflixis


Release Versions

More News From Conflixis

Conflixis Raises $4.2 Million in Seed Funding to Transform Conflicts of Interest (COI) Management in Healthcare

DALLAS & NEW YORK--(BUSINESS WIRE)--Conflixis, Inc., a data and risk intelligence company announced today $4.2 million in seed capital co-led by Lerer Hippeau and Origin Ventures, with additional investment from mark vc, Springtime Ventures, and continued support from early investor Crētiv Capital. This new funding will advance Conflixis’ mission to improve the healthcare ecosystem by ensuring every financial relationship is known, contextualized, and its influence on procurement, operational,...

Conflixis Releases 2024 Open Payments Report Shedding Light on Risk in Financial Relationships Across Healthcare

DALLAS & NEW YORK--(BUSINESS WIRE)--Conflixis, a new conflicts of interest risk management technology provider, today released its inaugural 2024 Open Payments Report, revealing critical insights into the financial relationships between healthcare providers and the pharmaceutical and medical device industries. The report uncovers patterns of potentially inappropriate remuneration and shows that although the Open Payments program has enhanced transparency, disclosure alone has not deterred healt...
Back to Newsroom